Research and Development Costs for New Drugs by Therapeutic Category: A Study of the U.S. Pharmaceutical Industry
Publication
, Journal Article
DiMasi, J; Hansen, R; Lasagna, L
Published in: PharmacoEconomics
1995
Duke Scholars
Published In
PharmacoEconomics
Publication Date
1995
Volume
7
Issue
2
Start / End Page
152 / 169
Related Subject Headings
- Health Policy & Services
- 14 Economics
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
DiMasi, J., Hansen, R., & Lasagna, L. (1995). Research and Development Costs for New Drugs by Therapeutic Category: A Study of the U.S. Pharmaceutical Industry. PharmacoEconomics, 7(2), 152–169.
DiMasi, Joseph, Ronald Hansen, and Louis Lasagna. “Research and Development Costs for New Drugs by Therapeutic Category: A Study of the U.S. Pharmaceutical Industry.” PharmacoEconomics 7, no. 2 (1995): 152–69.
DiMasi J, Hansen R, Lasagna L. Research and Development Costs for New Drugs by Therapeutic Category: A Study of the U.S. Pharmaceutical Industry. PharmacoEconomics. 1995;7(2):152–69.
DiMasi, Joseph, et al. “Research and Development Costs for New Drugs by Therapeutic Category: A Study of the U.S. Pharmaceutical Industry.” PharmacoEconomics, vol. 7, no. 2, 1995, pp. 152–69.
DiMasi J, Hansen R, Lasagna L. Research and Development Costs for New Drugs by Therapeutic Category: A Study of the U.S. Pharmaceutical Industry. PharmacoEconomics. 1995;7(2):152–169.
Published In
PharmacoEconomics
Publication Date
1995
Volume
7
Issue
2
Start / End Page
152 / 169
Related Subject Headings
- Health Policy & Services
- 14 Economics
- 11 Medical and Health Sciences